1Kayagaki N, Kawasaki A, Ebata T, et al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med,1995, 182(6): 1777～1783
2Cheng J, Zhou T, Liu C, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science, 1994, 263(5154): 1759～1762
3Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med, 1997, 336(16):1131-1141
4Yamaoka M, Yamaguchi S, Suzuki T, et al. Apoptosis in rat cardiac myocytes induced by Fas ligand: priming for Fasmediated apoptosis with doxorubicin. J Mol Cell Cardiol,2000, 32(6): 881～889
5Yamamura T, Nakamura H, Yamamoto T, et al. Fas expression and apoptosis correlate with cardiac dysfunction in patients with dilated cardiomyopathy. Jpn Circ J, 1999, 63(3): 149～154
6Nagata S. Apoptosis by death factor. Cell, 1997 Feb 7, 88(3):355-365
7Yamaguchi S, Yamaoka M, Okuyama M, et al. Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure. Am J Cardiol,1999, 83(10): 1500～1503 ,A8
8Nishigaki K, Minatoguchi S, Seishima M, et al. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J Am Coll Cardiol, 1997, 29(6): 1214～1220
9Okuyama M, Yamaguchi S, Nozaki N, et al. Serum levels of soluble form of Fas molecule in patients with congestive heart failure. Am J Cardiol, 1997, 79(12) :1698～1701
10Fiorina P,Astorri E, Albertini R, et al. Soluble antiapoptotic molecules and immune activation in chronic heart failure and unstable angina pectoris. J Clin Immunol,2000, 20(2) :101～106
3Kosmala W, Plaksej R, Strotmann JM, et al. Progression of left ventricular functional abnormalities in hypertensive patients with heart failure= an ultrasonic two-dimensional speckle track ing study [J] . Journal of the American Society of Echocardio- graphy, 2008, 21 (12)= 1309-1317.
4Mathur A, Agrawal VV, Thatai D, et al. Percutaneous trans- venous mitral commissurotomy for rheumatic mitral stenosis with impaired left ventricular function: all echocardiographic for follow-up study [J] . Int J Cardiol, 1996, 56 (3) 217-221.
5Dogan S, Aydin M, Gursurer M, et al. Prediction of subclini- cal left ventricular dysfunction with strain rate imaging in pa- tients with mild to moderate rheumatic mitral stenosis [J] . J Am Soc Echocardiogr, 2006, 19 (3) : 243-248.
6Galderisi M, Esposito R, Schiano V, et al. Correlates of global area strain in native hypertensive patients: a three-dimensional speckle-tracking echocardiography study [J]. Eur Heart J Car diovasc Imaging, 2012, 13 (9): 730-738.
